Kezar Life Sciences, Inc. (KZR) Social Stream



Kezar Life Sciences, Inc. (KZR): $0.69

0.02 (-3.27%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add KZR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#168 of 355

in industry

KEZAR LIFE SCIENCES INC (KZR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering KZR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 4 $15 $12 $13.5 $0.906 1390.07%
2021-11-16 5 $20 $15 $17.5 $0.906 1831.57%
2021-12-08 5 $20 $15 $18 $0.906 1886.75%
2022-03-18 5 $27 $19 $22.666 $0.906 2401.77%
2022-05-04 5 $22 $14 $19 $0.906 1997.13%
2022-06-28 5 $22 $14 $18.666 $0.906 1960.26%
2023-01-03 5 $21 $14 $17.333 $0.906 1813.13%
2023-03-16 5 $21 $14 $16.666 $0.906 1739.51%
2023-05-11 5 $21 $14 $16.666 $0.906 1739.51%
2023-05-12 5 $19 $13 $15.666 $0.906 1629.14%
2023-08-10 5 $19 $13 $15.666 $0.906 1629.14%
2023-08-11 5 $18 $4 $12.333 $0.906 1261.26%
2023-10-12 5 $20 $4 $13 $0.906 1334.88%
2023-11-14 5 $20 $2 $11.666 $0.906 1187.64%

The Trend in the Analyst Price Target


Over the past 24 months, KZR's average price target has gone down $1.83.

KZR reports an average of 781.85% for its upside potential over the past 35 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-16 5 21 14 16.666 3.820 336.28%
2023-05-12 5 19 14 16.000 2.620 510.69%
2023-08-10 5 19 13 15.666 2.050 664.2%
2023-08-11 5 18 4 12.333 1.510 716.75%
2023-10-12 5 20 4 13.000 0.916 1319.21%

KZR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.8 3 0 2 0 0 5

The Trend in the Broker Recommendations


KZR's average broker recommendation rating worsened by 0.8 over the prior 20 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KZR as an investment opportunity.

  • In the context of all US stocks, KEZAR LIFE SCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 1476.62% of them.
  • To contextualize these metrics, consider that out of all US stocks, KEZAR LIFE SCIENCES INC's number of analysts covering the stock is greater than 283.11% of them.
  • KZR has a lower variance in analysts' estimates than -388.58% of Pharmaceutical Products stocks.
  • KZR has a higher average analyst price target than 434.52% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KEZAR LIFE SCIENCES INC are XERS, VRCA, and ITRM.

Is KZR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!